We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

20 hedge funds and large institutions have $9.41M invested in Vaxart in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

1% less capital invested

Capital invested by funds: $9.55M → $9.41M (-$135K)

9% less funds holding

Funds holding: 2220 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

112% less ownership

Funds ownership: 168.2%56.2% (-112%)

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

VXRT Hedge Fund Activity: Q4 2019 in Review

20 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2019, worth a combined $9.41M — down 1.4% from $9.55M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VXRT and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Armistice Capital, adding an estimated $397K. The largest seller was Sabby Management, exiting entirely with an estimated $430K sold.

  • 20 institutional investors held Vaxart (VXRT) as of Q4 2019, down from 22 in Q3 2019.
  • Funds reported $9.41M of Vaxart stock for Q4 2019, down 1.4% quarter-over-quarter.
  • 3 funds opened new Vaxart positions in Q4 2019 and 5 closed out, a net change of -2 holders.
  • The largest Vaxart buyer in Q4 2019 was Armistice Capital, an estimated $397K added.
  • The largest Vaxart seller in Q4 2019 was Sabby Management, an estimated $430K sold.

Based on aggregated 13F filings for Q4 2019.